Molecular mechanisms of coronary artery disease risk at the PDGFD locus.
Hyun-Jung KimPaul ChengStanislao TravisanoChad WeldyJoão P MonteiroRamendra KunduTrieu D NguyenDisha SharmaHuitong ShiYi LinBoxiang LiuSaptarsi HaldarSimon JacksonThomas QuertermousPublished in: Nature communications (2023)
Genome wide association studies for coronary artery disease (CAD) have identified a risk locus at 11q22.3. Here, we verify with mechanistic studies that rs2019090 and PDGFD represent the functional variant and gene at this locus. Further, FOXC1/C2 transcription factor binding at rs2019090 is shown to promote PDGFD transcription through the CAD promoting allele. With single cell transcriptomic and histology studies with Pdgfd knockdown in an SMC lineage tracing male atherosclerosis mouse model we find that Pdgfd promotes expansion, migration, and transition of SMC lineage cells to the chondromyocyte phenotype. Pdgfd also increases adventitial fibroblast and pericyte expression of chemokines and leukocyte adhesion molecules, which is linked to plaque macrophage recruitment. Despite these changes there is no effect of Pdgfd deletion on overall plaque burden. These findings suggest that PDGFD mediates CAD risk by promoting deleterious phenotypic changes in SMC, along with an inflammatory response that is primarily focused in the adventitia.
Keyphrases
- coronary artery disease
- single cell
- percutaneous coronary intervention
- transcription factor
- cardiovascular events
- inflammatory response
- coronary artery bypass grafting
- mouse model
- rna seq
- genome wide association
- cardiovascular disease
- case control
- genome wide association study
- adipose tissue
- heart failure
- aortic stenosis
- lipopolysaccharide induced
- oxidative stress
- toll like receptor
- cystic fibrosis
- gene expression
- escherichia coli
- dna binding
- atrial fibrillation
- aortic valve
- breast cancer risk